Best Agrolife schedules Q4FY26 earnings call on May 28

Best Agrolife Limited has scheduled an analyst and investor conference call to discuss the operational and audited financial performance for the quarter and year ended March 31, 2026. The earnings call is set to take place on Thursday, May 28, 2026, at 3:00 PM IST. This follows the company's earlier announcement regarding its Board of Directors meeting scheduled for Wednesday, May 27, 2026, to consider and approve the audited financial results for FY26 and recommend a dividend, if any.

Conference Call Details

The management will discuss the financial outcomes for Q4 FY26 during the session. Key management participants include Mr. Surendra Sai Nallamalli, Whole-Time Director, and Mr. Vikas Jain, Chief Financial Officer. Participants are requested to dial in 5 minutes in advance of the start time.

Dial-in Information

Investors can join the call using the universal access numbers or international toll-free lines provided below.

Access Type	Contact Number
Universal Access Number	+91 22 6280 1341 +91 22 7115 8242
USA	18667462133
UK	08081011573
Hong Kong	800964448
Singapore	8001012045

The transcript of the conference call will be made available on the company's website within five working days after the call concludes.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+2.31%	+6.81%	-0.49%	-9.00%	-18.14%	-7.52%

Best Agrolife Limited has submitted its Monitoring Agency Report for the quarter ended March 31, 2026, to the BSE and the National Stock Exchange of India on May 07, 2026, in compliance with Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 162A(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report was prepared by Crisil Ratings Limited, the appointed Monitoring Agency, and pertains to the utilization of proceeds raised through a preferential issue of convertible warrants. The company, classified under the Pesticides & Agrochemicals sector, has its registered and corporate office at B-4, Bhagwan Dass Nagar, East Punjabi Bagh, New Delhi-110026.

Issue Background and Revised Proceeds

The preferential issue was open from December 17, 2024, to December 26, 2024, with an original issue size of Rs 200.00 crore. However, due to undersubscription of warrants — arising from non-receipt of the warrant subscription price equivalent to 25% of the Warrants Issue Price — the board of directors, via a resolution dated December 27, 2024, revised the issue size downward to Rs 150.00 crore. The revised allocation of proceeds across the stated objects is detailed below:

Metric:	Original Cost (Rs in crore)	Revised Cost (Rs in crore)
Capital Expenditure:	70.00	50.00
Working Capital Purpose:	120.00	90.00
General Corporate Purpose:	10.00	10.00
Total:	200.00	150.00

Utilization Status for Quarter Ended March 31, 2026

As of the quarter ended March 31, 2025, the company had received Rs 37.50 crore, representing 25% of the revised issue size, as the initial subscription amount. No additional amounts were received or utilized during the quarter ended March 31, 2026. The progress in utilization of the revised issue proceeds is summarized below:

Item Head:	Amount Proposed (Rs in crore)	Amount at Beginning of Quarter (Rs in crore)	Amount During Quarter (Rs in crore)	Amount at End of Quarter (Rs in crore)	Total Unutilized (Rs in crore)
Capital Expenditure:	50.00	Nil	Nil	Nil	50.00
Working Capital Purpose:	90.00	37.50	Nil	37.50	52.50
General Corporate Purpose:	10.00	Nil	Nil	Nil	10.00
Total:	150.00	37.50	Nil	37.50	112.50

The Monitoring Agency noted no utilization during the reported quarter across all three heads. The balance amount of Rs 112.50 crore is yet to be received from warrant holders. As per the notice to shareholders dated September 06, 2024, warrant holders have the option to convert the warrants into equity shares within 18 months from the date of allotment, i.e., December 27, 2024.

Deployment of Unutilised Proceeds

Based on the management undertaking and a certificate dated April 28, 2026, issued by M/S TATTVAM & Co, Chartered Accountants (Firm Registration Number: 015048N), the unutilised proceeds held in the Preferential Issue account of the company at Indian Bank (Account No. 7867851503) stood at Nil as of March 31, 2026, with no earnings or return on investment recorded for the quarter.

Key Risk: Warrant Exercise Price vs. Market Price

The Monitoring Agency flagged an unfavorable development relevant to investors. The company completed a stock split, reducing the face value of equity shares from Rs 10 each to Rs 1 each, and also executed a bonus issue in the ratio of 1:2 to existing shareholders. Following the stock split, the warrant exercise price was proportionately revised to Rs 64.00 per share, and bonus shares reserved for warrant holders are to be allotted upon exercise of conversion rights, subject to applicable laws.

As on May 04, 2026, the equity shares of the company were trading at approximately Rs 17.75 per share, significantly below the revised exercise price of Rs 64.00 per share. The Monitoring Agency highlighted that this disparity presents an inherent risk of non-exercise of conversion rights, which may impact the realization of the remaining proceeds from the warrants.

Compliance and Certifications

No deviation from the objects of the issue was observed, and no change in the means of finance was reported. The Monitoring Agency confirmed no major deviation over earlier reports. The report was prepared in accordance with Schedule XI of the SEBI ICDR Regulations and is supported by a peer-reviewed Independent Chartered Accountant Certificate dated April 28, 2026, from M/S TATTVAM & Co. The report has been signed by Shounak Chakravarty, Director, Ratings (LCG), Crisil Ratings Limited, and the submission to the exchanges was made by Aarti Arora, CS & Compliance Officer of Best Agrolife Limited. The report is also available on the company's website at www.bestagrolife.com .